
Sign up to save your podcasts
Or
Dr Benjamin Levy from Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial in Washington, DC, discusses important efficacy and safety data from 2024 related to the use of approved and investigational therapies for localized and advanced non-small cell lung cancer without a targetable mutation.
CME information and select publications here.
4.4
3030 ratings
Dr Benjamin Levy from Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial in Washington, DC, discusses important efficacy and safety data from 2024 related to the use of approved and investigational therapies for localized and advanced non-small cell lung cancer without a targetable mutation.
CME information and select publications here.
320 Listeners
40 Listeners
69 Listeners
76 Listeners
13 Listeners
17 Listeners
13 Listeners
0 Listeners
6 Listeners
116 Listeners
57 Listeners
124 Listeners
44 Listeners
29 Listeners
56 Listeners
86 Listeners
185 Listeners